Cocrystal Pharma, Inc. (COCP)

Cocrystal Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-17.98	-38.84	-14.19	-9.65	-48.17
Depreciation & Amortization	0.19	0.19	0.19	0.34	0.25
Share-Based Compensation	0.8	0.86	0.72	0.66	0.35
Other Operating Activities	2.33	16.36	0.55	-1.18	46
Operating Cash Flow	-14.67	-21.44	-12.72	-9.83	-1.56
Capital Expenditures	-0.12	-0.07	-0.05	-0.24	-0.15
Investing Cash Flow	-0.12	-0.07	-0.05	-0.24	-0.15
Share Issuance / Repurchase	4	0	38.51	35.78	6.64
Debt Issued / Paid	-0.01	-0.03	-0.04	-0.12	-0.21
Financing Cash Flow	3.99	-0.03	38.47	35.66	6.42
Net Cash Flow	-10.79	-21.54	25.7	25.59	4.72
Free Cash Flow	-14.78	-21.51	-12.77	-10.07	-1.71
Free Cash Flow Margin	-	-	-	-500.00%	-26.02%
Free Cash Flow Per Share	-1.53	-2.64	-1.73	-2.19	-0.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).